Related Experiment Video
Updated: Jul 10, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
Breaking the bonds: non-viral vectors become chemically dynamic
1Waisman Center, Department of Pediatrics and Medical Genetics, University of Wisconsin-Madison, Madison, Wisconsin, USA. jwolff@wisc.edu
Chemically dynamic synthetic vehicles improve nucleic acid delivery by using masked endosomolytic agents (MEAs). These agents release their payload in response to the endosomal environment, enhancing therapeutic potential for plasmid DNA (pDNA) and small interfering RNA (siRNA).
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Delivery
Background:
- Nucleic acid delivery (plasmid DNA, siRNA) is crucial for research and therapeutics.
- Non-viral synthetic vehicles (SVs) like lipoplexes and polyplexes are common delivery methods.
- Improving SV efficacy requires dynamic systems responsive to physiological cues.
Purpose of the Study:
- To develop chemically dynamic synthetic vehicles for enhanced nucleic acid delivery.
- To utilize masked endosomolytic agents (MEAs) for improved endosomal escape.
- To achieve efficient in vivo delivery of nucleic acids.
Main Methods:
- Design of SVs with chemically labile bonds.
- Incorporation of pH-sensitive masked endosomolytic agents (MEAs).
- Evaluation of MEA-containing dynamic polyconjugates (DPCs) for in vivo siRNA delivery.
Main Results:
- MEAs, when exposed to acidic endosomal environments, release their endosomolytic function.
- Dynamic polyconjugates (DPCs) incorporating MEAs demonstrated efficient in vivo siRNA delivery to hepatocytes.
- Labile bonds enable controlled release and prevent premature MEA activation.
Conclusions:
- Chemically dynamic SVs with masked endosomolytic agents offer a promising strategy for nucleic acid delivery.
- This approach balances efficient in vivo delivery with effective endosomal escape.
- The design allows for targeted release into the cytoplasm, improving therapeutic outcomes.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Viral Recombination
Viral Mutations
Inhibitors Of Virion Release
DNA Bacteriophages
Retrovirus Life Cycles
